Barbara Mikulski

“Delivery” has been in the spotlight this week as part of our #CuresNOW advocacy month. The delivery aspect of the discovery-development-delivery research pipeline is broad territory, from the research that informs improvements in our health care delivery system; to connecting patients to the right treatments at the right time, the first time; to creating a platform for new discovery and development to keep the cycle in motion, and the patient foremost in mind. Delivery week has included a blog post with testimonials about living with hydrocephalus, a new fact sheet on chronic kidney disease (CKD) and lots of action on social media -- including Research!America staffers sharing selfies...
Dear Research Advocate: I am writing a day early this week since all of us at Research!America will be engaged in our programs tomorrow. If you haven’€™t registered for the National Health Research Forum, there is still time to join us! More details here . Congress is back in town. The House will soon consider a simple, short-term continuing resolution (CR) to fund the government through early December. (Nobody wants a repeat of last year’€™s government shutdown at the beginning of the new fiscal year, October 1.) To offset funding requested by the Administration to help meet the Ebola crisis, as well as to adjust for certain other ’€œanomalies,’€ the CR bill includes a 0.0556% across-the-...
Dear Research Advocate: Today, Senator Tom Harkin (D-IA) ’€” one of the most effective and dedicated champions of medical and health research ever to serve in public office ’€” introduced major new legislation, the Accelerate Biomedical Research Act. This visionary legislation would increase the budget caps in order to boost National Institutes of Health (NIH) funding to $46.2 billion by FY 2021, a strategy for restoring NIH purchasing power without cutting into funding for other national priorities. You can view my statement on the legislation here and our thank you letter to the Senator here . It would be terrific if you would write a letter of support for the legislation and send a...
Dear Research Advocate: My colleagues at Research!America have shared the role as author of our weekly letter during my recent sabbatical. My thanks to them for providing timely and actionable information to our wide network. As I am ’€œre-entering’€ the Washington space, I have been struck by (1) the significantly worse condition of the roads ’€” potholes everywhere, and now even sinkholes in DC! I’€™ve been in several global capitals this spring, including in less-developed countries, and DC doesn’€™t look good in comparison. Via recent domestic travels, I can attest to the poor condition of our roads nationwide, taking a toll on vehicles and our economy, while eroding public confidence...
Dear Research Advocate: Today, Chairwoman Barbara Mikulski (D-MD) released the Senate’€™s 302(b) allocations , which were approved by the Appropriations Committee. As you know from last week, the House 302(b) allocation for the Labor-HHS subcommittee is approximately $1 billion less in fiscal year 2015 than it was in FY 14.The Senate’€™s allocation for FY 15 is roughly the same as it was in FY 14. The bottom line is that, as expected, we have our work cut out for us to achieve the increases needed for the National Institutes of Health (NIH) and our nation’€™s other health research agencies. Fortunately, Senator Mikulski and other leaders from both sides of the aisle understand the...
Dear Research Advocate: Following the lead of Budget Chairs Murray (D-WA) and Ryan (R-WI-01), Appropriations Chairs Mikulski (D-MD) and Rogers (R-KY-05) are trying to end the recent string of continuing resolutions and craft a funding compromise that advances the nation’€™s best interests. Congress may miss its January 15 deadline for appropriations, but it won’€™t likely shut down the government. We anticipate a short-term extension of the deadline while appropriators in both chambers work to craft an omnibus bill that reflects today’€™s priorities instead of blind, across-the-board cuts. It’€™s about time, you’€™re thinking (and I agree!) that Congress gets back to ’€œregular order.’€...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...
Dear Research Advocate, “2013 is a bad year to have a good idea,” was the bleak statement Laura Niedernhofer, MD, PhD, made about the impact of sequestration in a recent FASEB report . None of us want this year, or this country, to be a bad starting point for good ideas ’€¦ but that’s what’s at stake. Think about telling someone with a serious illness that this isn’t a good year, or a good decade, for research. Think about telling them that from here on out, it may always be a bad year for a good idea. Is there hope for turning this around? We have bipartisan support and we have champions; that we need more is a reality, but by no means an impossibility. Cancer research advocates gathered...
Dear Research Advocate, Glimmers of hope can be found in the dire funding situation we face under sequestration. The continuing resolution (C.R.) funding the government through the end of the fiscal year (September 30) included very small increases for NIH, CDC, NSF and FDA; AHRQ was flat funded. But the fact remains that these increases were overwhelmed by the effect of sequestration, which remains in place and will continue to weigh us down for 10 years unless overturned. Our champions in Congress are speaking out and taking a stand on behalf of research as the budget negotiation proceeds. Reps. McKinley (R-WV) and Markey (D-MA) have co-authored a letter to House appropriators calling for...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor